Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
about
Microbiology laboratory and the management of mother-child varicella-zoster virus infectionVaccination strategies in patients with solid organ transplant: evidences and future perspectivesImmunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel diseaseThe non-immunosuppressive management of childhood nephrotic syndromeCombination Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children: A Systematic Review and Meta-analysis of Immunogenicity and SafetyInfections and Brain DevelopmentVaccination recommendations for the hematology and oncology and post-stem cell transplant populationsVaccinations for pregnant womenReducing the burden of Herpes Zoster in ItalyWhat is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?Approved Antiviral Drugs over the Past 50 YearsAdult immunization-Need of the hourVaricella zoster vaccines and their implications for development of HSV vaccinesGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveTrends in varicella mortality in the United States: Data from vital statistics and the national surveillance system.Evaluation of a vaccination strategy by serosurveillance data: The case of varicella.Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial.Varicella vaccination in Europe - taking the practical approach.Varicella: epidemiological aspects and vaccination coverage in the Veneto Region.Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.Effect of varicella-zoster virus (VZV) fluorescent-antibody-to-membrane-antigen (FAMA) testing on sensitivity of determining VZV immunity in healthcare workers and on furlough days.Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management.Impact of varicella vaccine on varicella-zoster virus dynamicsVaricella susceptibility and transmission dynamics in Slovenia.Varicella zoster virus infection after allogeneic hematopoietic cell transplantation in children using a relatively short duration of acyclovir prophylaxis: A retrospective study.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerVaricella seroprevalence in the U.S.: data from the National Health and Nutrition Examination Survey, 1999-2004.Immunizations in children with inflammatory bowel disease treated with immunosuppressive therapyEffectiveness of varicella vaccine in children infected with HIVPrimary versus secondary failure after varicella vaccination: implications for interval between 2 dosesChickenpox at Ninety Four: A Case for Extending the Use of Varicella Vaccine in the UK.Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella.Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study.Herpes zoster among persons living with HIV in the current antiretroviral therapy era.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theDetection of antibodies to varicella-zoster virus in recipients of the varicella vaccine by using a luciferase immunoprecipitation system assay.Fatal varicella due to the vaccine-strain varicella-zoster virus.Clinical use of anti-TNF therapy and increased risk of infectionsProteasome inhibition and its therapeutic potential in multiple myelomaSuccesses and challenges in varicella vaccine
P2860
Q26738745-FF7E780E-8B54-4183-8A92-A3D159F78F62Q26739160-AF76D39C-AD19-4FF8-8B7B-EC59F861E50BQ26777330-DC7822DB-34BC-4CAA-A5CF-408F068034F4Q26778157-0133EDC3-3E29-4E82-99C3-351F1C6B65E0Q26778207-3650773E-BB70-4650-90A0-1B8E01DF7A04Q26778598-211F704C-BFD0-4225-9B49-FB58D3D66FBEQ26829398-2F33A6A6-AFD4-4A82-B026-3E5C2663C5CBQ26860740-0F941FCE-A6DD-4D67-A300-DFEC870E6CF4Q26998625-990D49BA-2C19-4DBE-9273-8BE112208AC9Q27687191-6BDEF100-8DCB-4B46-A457-AF6E801DF0B4Q27755387-531486B6-4355-44A9-91DB-96634493137DQ28077096-69B97A5B-1A61-48EA-952C-1B4009FB2E7BQ28280820-2AA7C3EB-2FA9-475E-AB82-749D96AA615AQ28388806-55F471B3-0D1E-41D1-B707-42229D1B30CDQ30899562-CC35AB91-6EFD-4293-B81F-8CA78648262DQ30908568-E59AAEC3-B6C8-47AD-98D5-670BC129D6E0Q33430135-20E04F7F-04BE-4EB2-BBAA-0B4F31CE69C1Q33454919-84958C48-9690-4929-A3AC-DFAB66592B0BQ33500864-B128B243-A96B-4E28-9AD3-5DC57D813C1FQ33558564-3C7F9B38-3CFB-4147-9E68-03447AF9121FQ33562799-510CCE3A-477F-4A13-95E6-BAE5823D533FQ33562804-60A595B7-D8CA-44B6-A4AD-BEAC48D4C2ECQ33591264-859A2D3F-69DE-4DD9-BF95-2C5B6310C2C0Q33614198-B49E3A10-5DC0-4A2C-8D6A-BC41FFB12F90Q33621313-730DF0EB-CD76-4727-94BD-8AD7B9BE5004Q33650105-AB1B43EA-C784-4435-A584-56D164D75B28Q33759666-061465C8-346D-4713-9B2B-CA63A0DE570FQ33842375-1912F922-8C86-45C1-BA36-9F5E4640FE4FQ33857101-12840B99-943A-4579-BAB7-D7A5A17BEDB6Q33880341-A780D576-D0B8-459D-925C-FB284E79E72CQ33943156-02309E19-9C13-4F6A-BD87-67A3246C2CE5Q34074644-8685E4CE-097A-49FB-ACDB-8E3B734F932CQ34101345-F3900DB4-D3AF-48AD-8E9B-6E4795278CFDQ34132884-0316680E-1CA0-432C-8921-40A04AA05136Q34212799-B7AC3FC6-9257-48F4-A8A7-416521357E12Q34260743-C53ECC45-C04B-4B30-8FA8-312F0AEF7264Q34271522-3BF4874A-5A99-436F-B29D-878FE397AE00Q34338096-F580AADD-305A-4002-8BCA-82AADFBF70C3Q34343036-2D143905-090E-436C-8E7C-D2F8CCEEAFBAQ34416710-F105A60F-0A44-420D-AC37-D37821905342
P2860
Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Prevention of varicella: recom ...... Immunization Practices (ACIP).
@ast
Prevention of varicella: recom ...... Immunization Practices (ACIP).
@en
Prevention of varicella: recom ...... ttee on Immunization Practices
@nl
type
label
Prevention of varicella: recom ...... Immunization Practices (ACIP).
@ast
Prevention of varicella: recom ...... Immunization Practices (ACIP).
@en
Prevention of varicella: recom ...... ttee on Immunization Practices
@nl
prefLabel
Prevention of varicella: recom ...... Immunization Practices (ACIP).
@ast
Prevention of varicella: recom ...... Immunization Practices (ACIP).
@en
Prevention of varicella: recom ...... ttee on Immunization Practices
@nl
P2093
P1476
Prevention of varicella: recom ...... Immunization Practices (ACIP).
@en
P2093
Advisory Committee on Immuniza ...... e Control and Prevention (CDC)
Dalya Güris
Jane F Seward
Mona Marin
Sandra S Chaves
Scott Schmid
P577
2007-06-01T00:00:00Z